Firalis
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- Huningue, Grand Est RBEAAGQAXNN3
-
- SAM.gov registration date
- Website
- firalis.com
- Founded
- 2008
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Sekisui Diagnostics, LLC | San Diego, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Mirimus, Inc. | NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Labcorp | Englewood, CO | 621511 Medical Laboratories |
| Fujirebio Diagnostics, Inc. | Malvern, PA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Numentus Technologies Inc. | Menlo Park, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Firalis is a leading biotechnology company specializing in cardiovascular biomarkers and diagnostic tools for preclinical and clinical applications. It is a for-profit corporate entity registered to receive federal awards, with an active registration in the System for Award Management (SAM.gov) until May 2023.
Firalis has received multiple prime contract awards from the Department of Health and Human Services Food and Drug Administration (FDA). These contracts involve providing specialized services related to profiling microRNA transcripts and conducting whole transcriptome assays in plasma samples from humans and mice. The work includes analyzing microRNA expression levels and performing diagnostics on cardiovascular biomarkers. The contracts awarded to Firalis by the FDA are firm-fixed-price purchase orders, with values ranging from around $52,000 to $161,845. The projects do not have any set-aside designations and are not limited to specific socioeconomic categories. The services provided by Firalis support the FDA's research efforts in areas such as drug development and understanding the effects of treatments on biomarkers and gene expression profiles.
Quick answers
Is Firalis registered in SAM.gov?
Firalis's SAM.gov registration expired on May 19, 2023.
What is Firalis's CAGE code?
Firalis's CAGE code is FBEE7, and its Unique Entity ID (UEI) is KKDHW3ENL7L4.
What is Firalis's most recent federal award?
Firalis's most recent federal contract award is Mirna whole transcriptome assay (WTA) service in human plasma samples (75F40122P00293), from Food and Drug Administration, on July 26, 2022.
On GovTribe
See Firalis's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors